NCT02625636 - A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

SAR438544

"Pharmaceutical form: solution~Route of administration: subcutaneous"

DRUG

placebo

"Pharmaceutical form: solution~Route of administration: subcutaneous"

DRUG

r-glucagon

"Pharmaceutical form: solution~Route of administration: subcutaneous"

Trial Locations (1)

Investigational Site Number 840001, Chula Vista